301 related articles for article (PubMed ID: 23684217)
1. Prevalence and factors associated with baseline chronic kidney disease in China: a 10-year study of 785 upper urinary tract urothelial carcinoma patients.
Xiong G; Chen X; Li X; Fang D; Zhang L; Yang L; Zhang L; Yao L; He Z; Zhou L
J Formos Med Assoc; 2014 Aug; 113(8):521-6. PubMed ID: 23684217
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
3. Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma.
Singla N; Gayed BA; Bagrodia A; Krabbe LM; Palazzi KL; Mirheydar H; Harrow B; Jacobs C; Youssef R; Darwish O; Sagalowsky A; Lotan Y; Derweesh I; Margulis V
Urol Oncol; 2015 Jun; 33(6):268.e1-7. PubMed ID: 25862284
[TBL] [Abstract][Full Text] [Related]
4. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
Xylinas E; Rink M; Margulis V; Clozel T; Lee RK; Comploj E; Novara G; Raman JD; Lotan Y; Weizer A; Roupret M; Pycha A; Scherr DS; Seitz C; Ficarra V; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Shariat SF;
BJU Int; 2013 Aug; 112(4):453-61. PubMed ID: 23464979
[TBL] [Abstract][Full Text] [Related]
5. Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population.
Fang D; Xiong G; Li X; Kang Y; Zhang L; Zhao G; Chen X; Yao L; Zhang X; Yu W; Gong K; Song Y; He Q; He Z; Zhou L; Guo Y
Urol Oncol; 2015 Feb; 33(2):66.e1-11. PubMed ID: 25240760
[TBL] [Abstract][Full Text] [Related]
6. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease.
Chen CY; Liao YM; Tsai WM; Kuo HC
J Formos Med Assoc; 2007 Dec; 106(12):992-8. PubMed ID: 18194904
[TBL] [Abstract][Full Text] [Related]
7. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy.
Raman JD; Lin YK; Kaag M; Atkinson T; Crispen P; Wille M; Smith N; Hockenberry M; Guzzo T; Peyronnet B; Bensalah K; Simhan J; Kutikov A; Cha E; Herman M; Scherr D; Shariat SF; Boorjian SA
Urol Oncol; 2014 Jan; 32(1):47.e9-14. PubMed ID: 24140248
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors for chronic kidney disease among HIV-infected antiretroviral therapy-naïve patients in mainland China: a multicenter cross-sectional study.
Cao Y; Gong M; Han Y; Xie J; Li X; Zhang L; Li Y; Song X; Zhu T; Li T
Nephrology (Carlton); 2013 Apr; 18(4):307-12. PubMed ID: 23311442
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
[TBL] [Abstract][Full Text] [Related]
11. Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a large Chinese center experience.
Fang D; Xiong GY; Li XS; Chen XP; Zhang L; Yao L; He ZS; Zhou LQ
J Formos Med Assoc; 2014 Nov; 113(11):820-7. PubMed ID: 24360737
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China.
Chen XP; Xiong GY; Li XS; Matin SF; Garcia M; Fang D; Wang TY; Yu W; Gong K; Song Y; He ZS; He Q; Zhou LQ
BJU Int; 2013 Nov; 112(7):917-24. PubMed ID: 23905945
[TBL] [Abstract][Full Text] [Related]
13. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma.
Kaag M; Trost L; Thompson RH; Favaretto R; Elliott V; Shariat SF; Maschino A; Vertosick E; Raman JD; Dalbagni G
BJU Int; 2014 Nov; 114(5):674-9. PubMed ID: 24314050
[TBL] [Abstract][Full Text] [Related]
14. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.
Messer JC; Terrell JD; Herman MP; Ng CK; Scherr DS; Scoll B; Boorjian SA; Uzzo RG; Wille M; Eggener SE; Lucas SM; Lotan Y; Shariat SF; Raman JD
Urol Oncol; 2013 Aug; 31(6):904-8. PubMed ID: 21906967
[TBL] [Abstract][Full Text] [Related]
15. Kidney disease progression in patients of upper tract urothelial carcinoma following unilateral radical nephroureterectomy.
Lee KH; Chen YT; Chung HJ; Liu JS; Hsu CC; Tarng DC
Ren Fail; 2016; 38(1):77-83. PubMed ID: 26513686
[TBL] [Abstract][Full Text] [Related]
16. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
[TBL] [Abstract][Full Text] [Related]
17. Comparison of postoperative estimated glomerular filtration rate between kidney donors and radical nephrectomy patients, and risk factors for postoperative chronic kidney disease.
Lee SH; Kim DS; Cho S; Kim SJ; Kang SH; Park J; Park SY; Chang SG; Jeon SH
Int J Urol; 2015 Jul; 22(7):674-8. PubMed ID: 26012527
[TBL] [Abstract][Full Text] [Related]
18. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
Chung SD; Huang KH; Lai MK; Huang CY; Chen CH; Pu YS; Yu HJ; Chueh SC
Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
[TBL] [Abstract][Full Text] [Related]
19. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
Grasso M; Fishman AI; Cohen J; Alexander B
BJU Int; 2012 Dec; 110(11):1618-26. PubMed ID: 22458598
[TBL] [Abstract][Full Text] [Related]
20. Fas expression in nephrectomized, non-cancerous specimens predicts post-nephrectomy chronic kidney disease progression in patients with renal and upper urinary tract malignancies.
Sejima T; Iwamoto H; Morizane S; Hinata N; Yao A; Isoyama T; Saito M; Amisaki T; Takenaka A
Urol Oncol; 2013 Nov; 31(8):1812-9. PubMed ID: 22591748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
